The class 1 protein (PorA) is a major component of the outer membrane of Neisseria meningitidis and functions as a cationic porin. The protein is particularly effective in generating a bactericidal immune response following infection and is therefore under investigation as a potential antigen for inclusion in new meningococcal vaccines. Studies on the vaccine potential of PorA would be facilitated by the production of pure protein, free from other components of the meningococcal outer membrane. In the current study, PorA was expressed from the heterologous host Escherichia coli as a C-terminal fusion to an inducible protein-splicing element (intein) with an N-terminal chitin-binding domain (CBD) (IMPACT-TWIN system). The CBD acted as an aff...
<div><p>Invasive meningococcal disease causes over 3500 cases each year in Europe, with particularly...
The SC protein is expressed by the strain of Neisseria meningitidis (44/76) used for production of t...
Meningococcal surface proteins capable of evoking a protective immune response are candidates for in...
The entire gene encoding the class 1 outer membrane protein of Neisseria meningitidis is located on ...
Meningoccal meningitis remains a severe life-threatening infection. Present vaccines to combat the d...
High level expression of meningococcal class 1 protein was achieved in Escherichia coli using the p-...
Infections with Neisseria meningitidis are characterized by life-threatening meningitis and septicem...
The PorA protein of Neisseria meningitidis (subtype P1.7,16) was expressed as a recombinant protein ...
Porins from different neisserial strains and species have been shown to have differences in both pri...
The previously determined nucleotide sequence of the porA gene, encoding the class 1 outer membrane ...
The porA gene from Neisseria meningitidis was cloned into the pRSETA vector and recombinant class 1 ...
There is a great need for vaccines against Neisseria meningitidis serogroup B. This is especially im...
One potential vaccine strategy in the fight against meningococcal disease involves the exploitation ...
Meningococcal meningitis is a severe life threatening disease for which no adequate vaccine exists. ...
OBJECTIVES: Outer membrane vesicle (OMV) vaccines are used against outbreaks of capsular group B Nei...
<div><p>Invasive meningococcal disease causes over 3500 cases each year in Europe, with particularly...
The SC protein is expressed by the strain of Neisseria meningitidis (44/76) used for production of t...
Meningococcal surface proteins capable of evoking a protective immune response are candidates for in...
The entire gene encoding the class 1 outer membrane protein of Neisseria meningitidis is located on ...
Meningoccal meningitis remains a severe life-threatening infection. Present vaccines to combat the d...
High level expression of meningococcal class 1 protein was achieved in Escherichia coli using the p-...
Infections with Neisseria meningitidis are characterized by life-threatening meningitis and septicem...
The PorA protein of Neisseria meningitidis (subtype P1.7,16) was expressed as a recombinant protein ...
Porins from different neisserial strains and species have been shown to have differences in both pri...
The previously determined nucleotide sequence of the porA gene, encoding the class 1 outer membrane ...
The porA gene from Neisseria meningitidis was cloned into the pRSETA vector and recombinant class 1 ...
There is a great need for vaccines against Neisseria meningitidis serogroup B. This is especially im...
One potential vaccine strategy in the fight against meningococcal disease involves the exploitation ...
Meningococcal meningitis is a severe life threatening disease for which no adequate vaccine exists. ...
OBJECTIVES: Outer membrane vesicle (OMV) vaccines are used against outbreaks of capsular group B Nei...
<div><p>Invasive meningococcal disease causes over 3500 cases each year in Europe, with particularly...
The SC protein is expressed by the strain of Neisseria meningitidis (44/76) used for production of t...
Meningococcal surface proteins capable of evoking a protective immune response are candidates for in...